Abstract:Ultra-small-sized iron oxide nanoparticles with good biocompatibility are regarded as promising alternatives for the gadolinium-based contrast agents, which are widely used as a positive contrast agent in magnetic resonance imaging (MRI). However, the current preparation of the iron oxide magnetic nanoparticles with small sizes usually involves organic solvents, increasing the complexity of hydrophilic ligand replacement and reducing the synthesis efficiency. It remains a great challenge to explore new iron oxide nanoparticles with good biocompatibility and a high T1 contrast effect. Here, we reported a cage-like protein architecture self-assembled by approximately 6–7 BSA (bovine serum albumin) subunits. The BSA nanocage was then used as a biotemplate to synthesize uniformed and monodispersed Fe2O3@BSA nanoparticles with ultra-small sizes (∼3.5 nm). The Fe2O3@BSA nanoparticle showed a high r1 value of 6.8 mM–1 s–1 and a low r2/r1 ratio of 10.6 at a 3 T magnetic field. Compared to Gd-DTPA, the brighter signal and prolonged angiographic effect of Fe2O3@BSA nanoparticles could greatly benefit steady-state and high-resolution imaging. The further in vivo and in vitro assessments of stability, toxicity, and renal clearance indicated a substantial potential as a T1 contrast agent in preclinical MRI.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c13825?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c13825</a>.TEM, size distribution, DLS, FTIR, SDS-PAGE, T1 and T2 relaxation time, T1-weighted MRI, absorption spectra, pH-dependent hydrodynamic size, live and dead stain, XPS, SQUID, and renal clearance (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c13825/suppl_file/am0c13825_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Fe3O4@astragalus polysaccharide core-shell nanoparticles for iron deficiency anemia therapy and magnetic resonance imaging in vivo

Construction of iron oxide nanoparticles modified with Angelica sinensis polysaccharide for the treatment of iron deficiency anemia

Study on the synthesis of iron-based nanomedicine assisted by angelica sinensis polysaccharide with enhanced retention performance and its application in anemia treatment

Fe3O4@Angelica sinensis polysaccharide nanoparticles as an ultralow-toxicity contrast agent for magnetic resonance imaging

Synthesis of Surface Modified Fe3O4 Super Paramagnetic Nanoparticles for Ultra Sound Examination and Magnetic Resonance Imaging for Cancer Treatment.

Fe3+@PDOPA‑b‑PSar Nanoparticles for Magnetic Resonance Imaging and Cancer Chemotherapy.

Synthesis of well-dispersed aqueous-phase magnetite nanoparticles and their metabolism as an MRI contrast agent for the reticuloendothelial system

Strategy to Prevent Cardiac Toxicity Induced by Polyacrylic Acid Decorated Iron MRI Contrast Agent and Investigation of Its Mechanism

Irregularly Shaped Iron Nitride Nanoparticles As a Potential Candidate for Biomedical Applications: from Synthesis to Characterization

Folic acid-conjugated superparamagnetic iron oxide nanoparticles for tumor-targeting MR imaging.

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

Preparation and Characterization of a Novel Polysaccharide-Iron(III) Complex in Auricularia auricula Potentially Used as an Iron Supplement

Developing Fe3O4 nanoparticles into an efficient multimodality imaging and therapeutic probe.

Fe-doped Copper Sulfide Nanoparticles for in Vivo Magnetic Resonance Imaging and Simultaneous Photothermal Therapy.

Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics

Irregularly Shaped {\Gamma}'-Fe4n Nanoparticles for Hyperthermia Treatment and T2 Contrast-Enhanced Magnetic Resonance Imaging with Minimum Dose

Functionalized Iron Oxide Nanoparticles for Both Dual-Modal Imaging and Erythropoiesis

Irregularly Shaped γ'-Fe4N Nanoparticles for Hyperthermia Treatment and T2 Contrast-Enhanced Magnetic Resonance Imaging with Minimum Dose

A T1/T2 dual functional iron oxide MRI contrast agent with super stability and low hypersensitivity benefited by ultrahigh carboxyl group density

In Situ One-Pot Synthesis of Fe 2 O 3 @BSA Core-Shell Nanoparticles as Enhanced T 1 -Weighted Magnetic Resonance Imagine Contrast Agents

Development of a novel polysaccharide-based iron oxide nanoparticle to prevent iron accumulation-related osteoporosis by scavenging reactive oxygen species